chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant on 02-JUL-2015 concerning a patient of an unknown age and gender. On 24-APR-2015, the patient was vaccinated with a dose of RECOMBIVAX HB 0.5 ml, lot # K010535, (expiration date, route and site of administration were not reported) that underwent 72 hours temperature excursion outside of the recommended range. No adverse effects had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
Loss of energy; Injection site redness/ red mark after thier last injection for COVID; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Loss of energy) and VACCINATION SITE ERYTHEMA (Injection site redness/ red mark after thier last injection for COVID) in an elderly female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced ASTHENIA (Loss of energy) and VACCINATION SITE ERYTHEMA (Injection site redness/ red mark after thier last injection for COVID). At the time of the report, ASTHENIA (Loss of energy) outcome was unknown and VACCINATION SITE ERYTHEMA (Injection site redness/ red mark after their last injection for COVID) had resolved. The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown. Concomitant medications details were not reported by the reporter.  Treatment details were not reported by the reporter.
I ask about name of patient, birthday and age of patient, and which vaccine and which dose need today.  Patient sat for 15 minutes after taking pfizer covid vaccine on 11/03/2021 and patient doing great and denies any kind of adverse reaction/symptoms.  I Contacted patient  after having second dose on 1/7/2022 and patient states that he is doing good and he denies any kind of adverse reaction/symptoms after having 2nd Pfizer Covid vaccine dose.
I had a stroke one week to the day from taking the  moderna vaccine. It affected my entire left side. Had weeks of physical therapy and still not back to normal. I have a long road ahead of me with rehab.
Information has been received from a health professional concerning a 7 year old male who in approximately 2000, between 1999 and 2001, was vaccinated with a dose of varicella virus vaccine live.  On approximately 02/01/2005, in the first week of February 2005, the patient experienced a very mild case of chickenpox.  Unspecified medical attention was sought and the patient is recovering.  No product quality complaint was involved.
Headache & exhaustion within 24 hours afterward. Trigeminal neuralgia & Bells Palsy within 3 months afterward.
Post vax, a lump approximately the size of a golf ball, formed on my arm at the site of the injection. Severe redness and swelling.
Pt reports arm was hurting immediately after getting flu and pneumovax shot. States she ran 101 degree temperature that night. Also c/o body aches, nausea and fatigue. Pt reports she could not raise her arms and could barely move her legs, pt states she has a red rash on the arm she rec'd the shots in and it also hot. Pt reports taking aspirin with Dramamine for s/s. Pt reports much better but not completely.
1 day after PREVNAR 13 had moderate effusion of knee with erythema, warmth, but nontender and FROM. No objective fever. Ambulatory.
Janssen -Covid 19-EUA  The patient was standing in observation and complained to me that she was dizzy. I sat her down and  Paramedic assessed the patient and recommended she be transported to the hospital.  The patient refused tranport and signed out AMA.  See Paramedic PCR for further details.  The patient stated she felt dizzy after her flu vaccine also.
Metallic taste in mouth within 1 minuteof getting the shot.; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 02Apr2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included calcium (MANUFACTURER UNKNOWN) and Prenatal Vitamins (MANUFACTURER UNKNOWN) for unknown indication. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Apr2021 at 16:31, the patient had experienced metallic taste in mouth with in one minute of getting the shot. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metallic taste in mouth within 1 minute of getting the shot was unknown at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a medical assistant refers to a 15 year old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 08-OCT-2018, the patient was vaccinated with improperly stored dose of VAQTA ped 0.5 ml vial (dose, frequency and route were not reported) (lot # R009953, expiry date: 12-JUN-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) for 3.5 hours from 06-SEP-2018. Previous excursion was 50.37°F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868: Original Case: 1809USA002868; US-009507513-1902USA009324: Original Case: 1902USA009323; US-009507513-1902USA009325: Original Case: 1902USA009323; US-009507513-1902USA009326: Original Case: 1902USA009323.
developed at 103 degree fever, chills and fatigue. took until early Sunday 4/11/21 to break fever. used Tylenol and ibuprofen and cool ice packs. also just rested r/t to fatigue.
I exp headaches, shoulder aches and really bad nausea. The headache from dose 2 was worse than first dose. I also exp numbness(limp feeling) bilateral arms. I was unable to cook had to be in bed for 2 days.
Patient inadvertently received the Pfizer 5-11 yr old bivalent booster dose instead of the Pfizer >12 years old bivalent booster dose as recommended. No adverse reactions reported.
Information has been received on 02/14/2002 from a grade school principle concerning a student who "in the past" was vaccinated with a dose of varicella virus vaccine live. On 02/14/2002, it was reported that the pt "recently" developed chicken pox. It was unknown if the pt sought medical attention. Additional info has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient was inoculated with ZOSTAVAX on or about 03-MAR-2008, administered by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 12-MAR-2016, the patient was treated by a Nurse Practitioner for the onset of a blistering vesicular rash accompanied by weakened immune systems and interference with her vision, which was diagnosed as herpes zoster, or shingles with ocular involvement. The patient was referred to a specialist and was treated at a clinic for the shingles that had spread to her eyes. The patient was prescribed valacyclovir for the management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Upon internal review herpes zoster, or shingles with ocular involvement was considered a medically significant event. Additional information has been requested.
2nd vaccine received on 2/22/2021, started feeling Atrial fibrulation on 2/23/2011 pulse 122-138.  Normally is 56-70.  Contacted cardiologist and he suggested to take double dose of Metoprolol.  After several hrs heart went back to normal.   Then on 2/27/2021 all the flu symptoms occured:  fewer (101.5), chills, muscle and joint aches.  Today is 3/1/2021, it looks like its better but not completely.
A non-serious spontaneous report of inadvertently administered expired FLUMIST was received from a health professional concerning an 11-year-old male. Neither past medical history nor concomitant medication was reported for this patient. The product expired in 15-Dec-2010. On 20-Dec-2010, the patient received expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Rash, red, plaque-like at injection site on left thigh approx. 4-5 cm in diameter. Red, rash, plaque-like at injection site on right thigh approx. 1-2cm in diameter. Fever.
This spontaneous report was received from a healthcare worker and refers to a 10 week old (also reported as 2 month old) patient. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 13-JAN-2016, the patient was inadvertently vaccinated with doses of M-M-R II (exact dose and route were not reported, lot # L012479, expiration date: 10-APR-2017), VAQTA (exact dose and route were not reported, lot # L02936, expiration date: 15-MAR-2017) and VARIVAX (Merck) (exact dose and route were not reported, lot # L024250, expiration date: 30-JUN-2017), that are supposed to be given at 12 months of age. No adverse effects were noted. Additional information has been requested.
blood sugar has been high/can't go below 200; dose received 3; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 34-year-old non-pregnant female patient received third dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in arm left on 02Nov2021 at 17:30 (at the age of 34-year-old) as dose 3 (booster), single for covid-19 immunization administered in pharmacy or drug store. The patient was not pregnant at time of vaccination. Patient's relevant medical history noted diabetes type 1 from an unknown date and unknown if ongoing. Patient's concomitant medications included included insulin (INSULIN) taken for unknown indication, start and stop date were not reported; levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced allergy. Historical vaccination included, patient previously received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 22Mar2021 (at the age of 34-year-old) as dose 2, single and received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, on an unspecified date as dose 1, single both for covid-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient reported that she had no serious reactions to the first 2 shots. However, the booster shot which was received on 02Nov2021, made the patient feel much worse but patient was concerned because the blood sugar had been high for 5 days (event onset captured as 02Nov2021) at the time of this report (reported as now). Even without eating, the patient could not go below 200 even after taking lots of extra insulin. The patient received treatment with insulin. Hospitalization prolonged was noted as no. The patient underwent lab tests and procedures which included blood glucose increased resulted as high on 02Nov2021. Outcome of the event blood sugar has been high/can't go below 200 was not recovered.  Information about lot/batch number not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected
THROWING UP ALL THE TIME FOR TWO MONTHS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced throwing up all the time for two months. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of throwing up all the time for two months was not reported. This report was non-serious.
Migraine attack lasting 37 days resulting in steirod treatment (prednisone) for 15 days (currently undergoing)
No symptomatic side effects reported. No additional AE; Patient was administered Rotateq after it's expiration date / Inadvertently administered expired vaccine; This spontaneous report has been received from a registered nurse, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 24-OCT-2022, the patient was inadvertently vaccinated with expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milligram (lot number 1742415 has been verified to be valid for rotavirus vaccine, live, oral, pentavalent (ROTATEQ), expiration date reported and validated as 12-OCT-2022), administered orally as prophylaxis (strength was not provided) (Expired product administered).  No symptomatic side effects reported. No additional adverse event (AE) details.
Throat pain; This case was reported by a physician via sales rep and described the occurrence of throat pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced throat pain. On an unknown date, the outcome of the throat pain was unknown.   It was unknown if the reporter considered the throat pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a throat pain after Shingrix dose. The reporter did not agree to follow up from GSK.
pt recv vax & devel a hearing loss;MD reported the same exp w/another pt;
I woke up at 3:00am on March 16, 2021 with headache, body ache, chills, tiredness, and temp of 101. By the next my temp was down to 99 and a mild headache persisted. As of March 2017 mild headache and tiredness still exist.
Nauseous in the morning after the shot; Pain in arm overnight after injection (same arm as injection); This is a spontaneous report from a contactable consumer. A 26-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration on 04Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 04Mar2021, the patient felt nauseous in the morning after the shot and pain in arm overnight after injection, in the same arm as injection. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Mar2021, the patient underwent COVID-19 virus test and the result was unknown. The clinical outcome of the event nauseous in the morning after the shot was resolved and of pain in arm overnight after injection, in the same arm as injection was resolved on 05Mar2021.   No follow-up attempts are possible. No further information is expected.
Saw Doctor for the first time on 3/29/2021. I was noting significant pain in my left shoulder. I couldn't raise it up without pain. There was numbness, tingling, and pain down the arm. She put me in physical therapy for 10-12 weeks with no improvement. PT went on from 4/9/2021-6/2021. I went and saw Doctor again on 9/9/2021, then I was continuing to have significant difficulties so that's when I saw Dr. from orthopedics on 10/13/2021. They did MRIs, then I had a follow up visit with him on 10/25 to discuss my options. My options were: they could do some cortisone to decrease inflammation and improve mobility and improve pain. Or surgery. I chose to do a shot and not do surgery as long as possible. But I continue to have pain in the arm, and I've never had any injuries to the shoulder that I can remember. Degenerated the muscle tissue in that arm. Both of the physical therapists and doctors have noted that they've seen people dealing with this before. Another health event: I have been in menopause for 3 years or so. I all of a sudden started bleeding again. I went and talked to my doctor at my annual physical on 9/9/2021 because I thought it was strange and they said it should not happen. I ended up getting surgery because of this. I started bleeding in July 2021 and I didn't think it was a big deal until 9/9/2021 and they did some tests and they found some growth in my uterus. They sent me to a specialist. They noted thickened endometrium and they tried to do a biopsy and it was unsuccessful. They ended up having to do the biopsy through surgery on 01/10/2022. Recovery: No on shoulder, Vaginal bleeding has discontinued.
Lightheaded and flush for about 15 minutes Light flashes, leg weakness, severe headache for 30 minutes  HR-87 BP-130/89 Acetaminophen was given
Pt has cellulitis of left deltoid then spread to left arm. Pt was treated with oral cephalexin and is not improving and pt was admitted, treated with IV ZOSYN at hospital discharged with Levofloxacin x 7 days.
TIRED; NUMB FACE,PRIVATE AREA,TONGUE,LEGS AND SKIN(NO PAIN SENSATION IN TONGUE WHILE BITING); DIARRHEA; HEAD CLOUDINESS; BODY ACHE WHILE IN SLEEP; NAUSEA; This spontaneous report received from a patient concerned a 44 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypothyroidism. The patient had no history of anaphylaxis reaction. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 041A21A expiry: unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Concomitant medications included levothyroxine sodium for hypothyroidism. On 06-APR-2021, the subject experienced numb face, private area, tongue, legs and skin (no pain sensation in tongue while biting). On 06-APR-2021, the subject experienced diarrhea. On 06-APR-2021, the subject experienced head cloudiness. On 06-APR-2021, the subject experienced body ache while in sleep. On 06-APR-2021, the subject experienced nausea. On 07-APR-2021, the subject experienced tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, head cloudiness, and body ache while in sleep on 06-APR-2021, had not recovered from numb face, private area, tongue, legs and skin(no pain sensation in tongue while biting), and the outcome of nausea and tired was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious.
A recent Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (A recent Covid-19 infection) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (A recent Covid-19 infection). At the time of the report, COVID-19 (A recent Covid-19 infection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test positive: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient received Initial booster dose. No treatment information was provided.
Patient developed uveitis in the right eye.  Patient was treated by opthalmologist starting 8/8/19 with prednisolone eye drops from 8/8/19 until current time and cyclogyl drops from 8/8/19 until 8/13/19.  Patient reported achy dull eye pain with redness (similar to conjunctivitis) for the first two to three days after vaccine administered.  Patient self treated with ibuprofen 200 mg with no improvement in symptoms for two days. She then went to primary care on 08/07/2019 and was prescribed polymyxin b - trimethoprim eyedrops which she used for one day before going to opthalmologist.
Parent reported rash after 4 mo set of vaccines; therefore only DTaP & Hep B were administered at 6 mo (since Hep B not given at 4 mo). Within 5 minutes of vaccine administration IM, pt began developing a red rash to neck and face but appeared different than rash at 4 months. Pt was given BENDARYL in office and told to give Q 6 hours until clear. Pt was seen 2 more times over the next 5 days.
1MAY91 1st inject of series; 3MAY91 slept all day- very very tired; Continued tiredness w/addition of lt neck & shoulder pain & soreness starting about 8MAY91;